Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or sp...
Saved in:
| Published in | Nature communications Vol. 14; no. 1; pp. 580 - 18 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
03.02.2023
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation.
SARS-CoV-2 variants of concern continue to emerge, reducing vaccine efficacy and limiting therapeutic options. Here, Chen and colleagues describe the identification and design of shark nanobodies with pansarbecovirus activity. |
|---|---|
| AbstractList | SARS-CoV-2 variants of concern continue to emerge, reducing vaccine efficacy and limiting therapeutic options. Here, Chen and colleagues describe the identification and design of shark nanobodies with pansarbecovirus activity. Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation. SARS-CoV-2 variants of concern continue to emerge, reducing vaccine efficacy and limiting therapeutic options. Here, Chen and colleagues describe the identification and design of shark nanobodies with pansarbecovirus activity. Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation.SARS-CoV-2 variants of concern continue to emerge, reducing vaccine efficacy and limiting therapeutic options. Here, Chen and colleagues describe the identification and design of shark nanobodies with pansarbecovirus activity. Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation.Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation. Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation. Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation. |
| ArticleNumber | 580 |
| Author | Krebs, Shelly J. Hart, Tricia Polonis, Victoria R. David, Sapna Paquin-Proulx, Dominic Chang, William C. Kuklis, Caitlin Thomas, Paul V. Matz, Hanover Kummer, Larry Broder, Christopher C. Doranz, Benjamin J. Peterson, Caroline E. Dussupt, Vincent Dooley, Helen Golub, Emily S. King, Jocelyn Gromowski, Gregory D. Hajduczki, Agnes Laing, Eric D. Lewitus, Eric Dawit, Layla Choe, Misook Bai, Hongjun Swafford, Isabella Joyce, M. Gordon Williams, Jazmean K. Soman, Sandrine Chen, Wei-Hung Rees, Phyllis A. Wieczorek, Lindsay Zemil, Michelle Yan, Lianying Ajayi, Adelola B. Sterling, Spencer L. Rolland, Morgane Modjarrad, Kayvon Martinez, Elizabeth J. Mayer, Sandra V. Hill, Thomas M. Corbitt, Courtney Sankhala, Rajeshwer S. Davidson, Edgar Duso, Debora Reiley, William W. |
| Author_xml | – sequence: 1 givenname: Wei-Hung orcidid: 0000-0003-3724-9195 surname: Chen fullname: Chen, Wei-Hung organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 2 givenname: Agnes surname: Hajduczki fullname: Hajduczki, Agnes organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 3 givenname: Elizabeth J. orcidid: 0000-0002-7755-7056 surname: Martinez fullname: Martinez, Elizabeth J. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 4 givenname: Hongjun orcidid: 0000-0002-3501-3974 surname: Bai fullname: Bai, Hongjun organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 5 givenname: Hanover surname: Matz fullname: Matz, Hanover organization: Department of Microbiology and Immunology, University of Maryland School of Medicine, Institute of Marine and Environmental Technology – sequence: 6 givenname: Thomas M. surname: Hill fullname: Hill, Thomas M. organization: Department of Microbiology and Immunology, University of Maryland School of Medicine, Institute of Marine and Environmental Technology – sequence: 7 givenname: Eric surname: Lewitus fullname: Lewitus, Eric organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 8 givenname: William C. orcidid: 0000-0003-4967-6426 surname: Chang fullname: Chang, William C. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 9 givenname: Layla surname: Dawit fullname: Dawit, Layla organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 10 givenname: Caroline E. surname: Peterson fullname: Peterson, Caroline E. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 11 givenname: Phyllis A. surname: Rees fullname: Rees, Phyllis A. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 12 givenname: Adelola B. surname: Ajayi fullname: Ajayi, Adelola B. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 13 givenname: Emily S. surname: Golub fullname: Golub, Emily S. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 14 givenname: Isabella orcidid: 0000-0001-8638-2772 surname: Swafford fullname: Swafford, Isabella organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 15 givenname: Vincent orcidid: 0000-0002-8579-6356 surname: Dussupt fullname: Dussupt, Vincent organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 16 givenname: Sapna surname: David fullname: David, Sapna organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 17 givenname: Sandra V. surname: Mayer fullname: Mayer, Sandra V. organization: Henry M. Jackson Foundation for the Advancement of Military Medicine, Viral Diseases Branch, Walter Reed Army Institute of Research – sequence: 18 givenname: Sandrine surname: Soman fullname: Soman, Sandrine organization: Viral Diseases Branch, Walter Reed Army Institute of Research – sequence: 19 givenname: Caitlin orcidid: 0000-0002-9974-6640 surname: Kuklis fullname: Kuklis, Caitlin organization: Viral Diseases Branch, Walter Reed Army Institute of Research – sequence: 20 givenname: Courtney surname: Corbitt fullname: Corbitt, Courtney organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, Viral Diseases Branch, Walter Reed Army Institute of Research – sequence: 21 givenname: Jocelyn orcidid: 0000-0003-3348-1632 surname: King fullname: King, Jocelyn organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, Viral Diseases Branch, Walter Reed Army Institute of Research – sequence: 22 givenname: Misook surname: Choe fullname: Choe, Misook organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 23 givenname: Rajeshwer S. surname: Sankhala fullname: Sankhala, Rajeshwer S. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 24 givenname: Paul V. surname: Thomas fullname: Thomas, Paul V. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine – sequence: 25 givenname: Michelle orcidid: 0000-0002-1700-6658 surname: Zemil fullname: Zemil, Michelle organization: U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 26 givenname: Lindsay surname: Wieczorek fullname: Wieczorek, Lindsay organization: Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 27 givenname: Tricia surname: Hart fullname: Hart, Tricia organization: Trudeau Institute – sequence: 28 givenname: Debora surname: Duso fullname: Duso, Debora organization: Trudeau Institute – sequence: 29 givenname: Larry surname: Kummer fullname: Kummer, Larry organization: Trudeau Institute – sequence: 30 givenname: Lianying surname: Yan fullname: Yan, Lianying organization: Department of Microbiology and Immunology, Uniformed Services University – sequence: 31 givenname: Spencer L. surname: Sterling fullname: Sterling, Spencer L. organization: Department of Microbiology and Immunology, Uniformed Services University – sequence: 32 givenname: Eric D. surname: Laing fullname: Laing, Eric D. organization: Department of Microbiology and Immunology, Uniformed Services University – sequence: 33 givenname: Christopher C. orcidid: 0000-0001-5382-0510 surname: Broder fullname: Broder, Christopher C. organization: Department of Microbiology and Immunology, Uniformed Services University – sequence: 34 givenname: Jazmean K. surname: Williams fullname: Williams, Jazmean K. organization: Integral Molecular – sequence: 35 givenname: Edgar surname: Davidson fullname: Davidson, Edgar organization: Integral Molecular – sequence: 36 givenname: Benjamin J. orcidid: 0000-0002-8245-3083 surname: Doranz fullname: Doranz, Benjamin J. organization: Integral Molecular – sequence: 37 givenname: Shelly J. orcidid: 0000-0003-1136-1760 surname: Krebs fullname: Krebs, Shelly J. organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 38 givenname: Victoria R. surname: Polonis fullname: Polonis, Victoria R. organization: U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 39 givenname: Dominic orcidid: 0000-0003-1407-3414 surname: Paquin-Proulx fullname: Paquin-Proulx, Dominic organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 40 givenname: Morgane orcidid: 0000-0003-3650-8490 surname: Rolland fullname: Rolland, Morgane organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Walter Reed Army Institute of Research – sequence: 41 givenname: William W. surname: Reiley fullname: Reiley, William W. organization: Trudeau Institute – sequence: 42 givenname: Gregory D. orcidid: 0000-0003-4576-4277 surname: Gromowski fullname: Gromowski, Gregory D. organization: Viral Diseases Branch, Walter Reed Army Institute of Research – sequence: 43 givenname: Kayvon surname: Modjarrad fullname: Modjarrad, Kayvon organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research – sequence: 44 givenname: Helen orcidid: 0000-0002-2570-574X surname: Dooley fullname: Dooley, Helen email: hdooley@som.umaryland.edu organization: Department of Microbiology and Immunology, University of Maryland School of Medicine, Institute of Marine and Environmental Technology – sequence: 45 givenname: M. Gordon orcidid: 0000-0002-6808-7232 surname: Joyce fullname: Joyce, M. Gordon email: gjoyce@eidresearch.org organization: Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36737435$$D View this record in MEDLINE/PubMed https://www.osti.gov/servlets/purl/2423606$$D View this record in Osti.gov |
| BookMark | eNp9Uk1vEzEUtFARLaF_gANa0QuXBX-t7b0gVREflSohEeBqeW1v4rCxg-0NLb8ep9tA20N9sWXPjOe9N8_BkQ_eAvASwbcIEvEuUUQZryEmNWEIsvrqCTjBkKIacUyO7pyPwWlKa1gWaZGg9Bk4JowTTklzAuRipeLPyisfumCcTdVvl1fVNmTrc7U4_7qo5-FHjStvxxzV4P44v6yUzm7n8nWlvKm6GJSpkoqd1WHn4piqaA-IF-Bpr4ZkT2_3Gfj-8cO3-ef68suni_n5Za0bxnOttObQdAbptqeGMmgFF6pXBlPaQqtFb3pjOG5KVZp0XUeYMD1VnDZEWELJDFxMuiaotdxGt1HxWgbl5M1FiEupYnZ6sFK0orcCF5WeUiasahrMFTZQUdQrLIrW-0lrO3Yba3TpRKn8nuj9F-9Wchl2shUtK36LwOtJIKTsZNIuW73SwXurs8QUEwZZAb25_SWGX6NNWW5c0nYYlLdhTBJzThCihPACPXsAXYcx-tLPPQqjluIy5xl4ddf2P7-HYReAmAA6hpSi7WVxprIL-yrcIBGU-2jJKVqyREveREteFSp-QD2oP0oiEykVsF_a-N_2I6y_QTXiAQ |
| CitedBy_id | crossref_primary_10_3390_ph16060863 crossref_primary_10_1016_j_fsi_2023_108807 crossref_primary_10_1186_s12951_025_03243_y crossref_primary_10_3390_md23010028 crossref_primary_10_3390_md21090496 crossref_primary_10_1016_j_apsb_2025_02_012 crossref_primary_10_1016_j_fsi_2023_108986 crossref_primary_10_1016_j_lanmic_2024_100974 crossref_primary_10_1016_j_talanta_2023_124937 crossref_primary_10_1093_pnasnexus_pgad403 crossref_primary_10_1016_j_antiviral_2024_105898 crossref_primary_10_1016_j_antiviral_2024_105820 crossref_primary_10_1016_j_foodchem_2024_141298 crossref_primary_10_1039_D4CC06442A crossref_primary_10_1016_j_jhazmat_2024_133821 crossref_primary_10_1016_j_bbadva_2025_100149 crossref_primary_10_1021_acsptsci_3c00042 crossref_primary_10_1186_s12951_024_02573_7 crossref_primary_10_3389_fimmu_2023_1257042 crossref_primary_10_3390_ijms252312879 crossref_primary_10_1038_s41467_023_44265_0 crossref_primary_10_1016_j_btre_2023_e00803 |
| Cites_doi | 10.1038/s41586-020-2852-1 10.1016/S0161-5890(03)00084-1 10.1073/pnas.0508341103 10.4161/19420862.2015.989032 10.1039/C3OB42251H 10.1016/j.jim.2010.12.016 10.1146/annurev-animal-021419-083831 10.1073/pnas.0507074103 10.1073/pnas.2101918118 10.1073/pnas.0808116105 10.1002/eji.200425760 10.1016/j.dci.2020.103873 10.1016/j.cell.2021.02.026 10.1073/pnas.2106433118 10.1186/s12951-021-00768-w 10.1016/j.molimm.2011.06.437 10.1038/374168a0 10.1038/s41467-021-27611-y 10.1016/j.cell.2020.04.031 10.1038/s41590-021-01068-z 10.1080/19420862.2021.1958663 10.1126/science.abb2507 10.1126/scitranslmed.abi5735 10.1016/j.jbc.2021.101202 10.1038/s41541-021-00392-7 10.1371/journal.ppat.1009328 10.1016/j.chom.2020.06.010 10.1038/nrmicro.2016.81 10.1016/S1473-3099(20)30317-0 10.1073/pnas.1517719113 10.1126/science.abe6230 10.1038/s41586-021-03676-z 10.1073/pnas.2008281117 10.1007/s12038-020-00114-6 10.1126/science.abe4747 10.1016/j.jmb.2006.12.045 10.1038/s41598-021-82833-w 10.1159/000507423 10.15252/embr.202052325 10.1128/JVI.02041-07 10.1016/j.celrep.2021.110143 10.1016/j.immuni.2021.08.015 |
| ContentType | Journal Article |
| Copyright | This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 – notice: 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| CorporateAuthor | Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS) |
| CorporateAuthor_xml | – name: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS) |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 OIOZB OTOTI 5PM DOA |
| DOI | 10.1038/s41467-023-36106-x |
| DatabaseName | Open Access Journals from Springer Nature CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Database ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Advanced Technologies & Aerospace Database (NC LIVE) ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic OSTI.GOV - Hybrid OSTI.GOV PubMed Central (Full Participant titles) Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2041-1723 |
| EndPage | 18 |
| ExternalDocumentID | oai_doaj_org_article_898fe823bbf4468ea5527a2d0a41fa28 PMC9896449 2423606 36737435 10_1038_s41467_023_36106_x |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: United States Department of Defense | Defense Health Agency (DHA) grantid: W81XWH-18-2-0040 funderid: https://doi.org/10.13039/100009898 – fundername: NIGMS NIH HHS grantid: P30 GM124165 – fundername: NIH HHS grantid: S10 OD021527 – fundername: ; grantid: W81XWH-18-2-0040 |
| GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K COVID DWQXO FR3 GNUQQ H94 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 SOI 7X8 OIOZB OTOTI 5PM PUEGO |
| ID | FETCH-LOGICAL-c567t-acc70dbd1c9f4d460e878afad24490ec8fdfdd725204c3bbb368df4a74538e343 |
| IEDL.DBID | M48 |
| ISSN | 2041-1723 |
| IngestDate | Wed Aug 27 01:13:06 EDT 2025 Thu Aug 21 18:38:05 EDT 2025 Mon Jan 27 02:26:14 EST 2025 Thu Jul 10 23:13:20 EDT 2025 Wed Aug 13 04:11:00 EDT 2025 Wed Feb 19 02:25:22 EST 2025 Tue Jul 01 00:58:39 EDT 2025 Thu Apr 24 22:57:29 EDT 2025 Fri Feb 21 02:40:00 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c567t-acc70dbd1c9f4d460e878afad24490ec8fdfdd725204c3bbb368df4a74538e343 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 AC02-06CH11357 USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF) |
| ORCID | 0000-0002-6808-7232 0000-0003-4576-4277 0000-0002-8579-6356 0000-0002-9974-6640 0000-0001-8638-2772 0000-0002-3501-3974 0000-0003-4967-6426 0000-0003-3724-9195 0000-0002-2570-574X 0000-0003-1136-1760 0000-0003-1407-3414 0000-0002-1700-6658 0000-0002-7755-7056 0000-0001-5382-0510 0000-0003-3650-8490 0000-0002-8245-3083 0000-0003-3348-1632 0000000345764277 0000000285796356 0000000314073414 0000000333481632 000000022570574X 0000000282453083 0000000268087232 0000000337249195 0000000186382772 0000000311361760 0000000299746640 0000000153820510 0000000235013974 0000000277557056 0000000349676426 0000000336508490 0000000217006658 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-023-36106-x |
| PMID | 36737435 |
| PQID | 2772194272 |
| PQPubID | 546298 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_898fe823bbf4468ea5527a2d0a41fa28 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9896449 osti_scitechconnect_2423606 proquest_miscellaneous_2773114337 proquest_journals_2772194272 pubmed_primary_36737435 crossref_citationtrail_10_1038_s41467_023_36106_x crossref_primary_10_1038_s41467_023_36106_x springer_journals_10_1038_s41467_023_36106_x |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-02-03 |
| PublicationDateYYYYMMDD | 2023-02-03 |
| PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-03 day: 03 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England – name: United States |
| PublicationTitle | Nature communications |
| PublicationTitleAbbrev | Nat Commun |
| PublicationTitleAlternate | Nat Commun |
| PublicationYear | 2023 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Stefan (CR28) 2021; 13 Sreepadmanabh, Sahu, Chande (CR8) 2020; 45 Pymm (CR27) 2021; 118 King (CR19) 2021; 118 Xiang (CR23) 2020; 370 Wrapp (CR21) 2020; 367 Ahmad (CR24) 2021; 297 Becker (CR6) 2008; 105 Ciotti (CR2) 2019; 64 Dooley, Stanfield, Brady, Flajnik (CR12) 2006; 103 Criscitiello, Saltis, Flajnik (CR15) 2006; 103 Xu (CR32) 2021; 595 Greenberg (CR13) 1995; 374 Stanfield, Dooley, Verdino, Flajnik, Wilson (CR16) 2007; 367 Dearlove (CR1) 2020; 117 Modjarrad, Kim (CR4) 2020; 20 Dooley, Flajnik, Porter (CR11) 2003; 40 Zielonka (CR9) 2015; 7 Lu (CR26) 2021; 19 Muyldermans (CR10) 2021; 9 Dooley, Flajnik (CR41) 2005; 35 Valenzuela Nieto (CR29) 2021; 11 Yao (CR31) 2021; 17 de Wit, van Doremalen, Falzarano, Munster (CR3) 2016; 14 Barnes (CR35) 2020; 588 Huo (CR36) 2020; 28 Menachery (CR7) 2016; 113 Joyce (CR17) 2021; 37 Berthelmann, Lach, Grawert, Groll, Eichler (CR37) 2014; 12 Wrapp (CR22) 2020; 181 Dussupt (CR34) 2021; 22 Ackerman (CR42) 2011; 366 Wuertz (CR20) 2021; 6 Koenig (CR25) 2021; 371 Sheahan (CR5) 2008; 82 Ubah (CR33) 2021; 12 Goodchild, Dooley, Schoepp, Flajnik, Lonsdale (CR40) 2011; 48 Matz, Munir, Logue, Dooley (CR14) 2021; 115 Winkler (CR38) 2021; 184 Wagner (CR30) 2021; 22 Ullah (CR39) 2021; 54 Joyce (CR18) 2022; 14 MG Joyce (36106_CR18) 2022; 14 Q Lu (36106_CR26) 2021; 19 E de Wit (36106_CR3) 2016; 14 SA Goodchild (36106_CR40) 2011; 48 M Sreepadmanabh (36106_CR8) 2020; 45 AS Greenberg (36106_CR13) 1995; 374 B Dearlove (36106_CR1) 2020; 117 H Yao (36106_CR31) 2021; 17 TR Wagner (36106_CR30) 2021; 22 Y Xiang (36106_CR23) 2020; 370 ME Ackerman (36106_CR42) 2011; 366 MM Becker (36106_CR6) 2008; 105 KM Wuertz (36106_CR20) 2021; 6 H Dooley (36106_CR11) 2003; 40 G Valenzuela Nieto (36106_CR29) 2021; 11 S Zielonka (36106_CR9) 2015; 7 D Wrapp (36106_CR22) 2020; 181 D Wrapp (36106_CR21) 2020; 367 P Pymm (36106_CR27) 2021; 118 V Dussupt (36106_CR34) 2021; 22 CO Barnes (36106_CR35) 2020; 588 H Dooley (36106_CR41) 2005; 35 M Ciotti (36106_CR2) 2019; 64 T Sheahan (36106_CR5) 2008; 82 H Matz (36106_CR14) 2021; 115 ES Winkler (36106_CR38) 2021; 184 J Ahmad (36106_CR24) 2021; 297 PA Koenig (36106_CR25) 2021; 371 MA Stefan (36106_CR28) 2021; 13 I Ullah (36106_CR39) 2021; 54 MF Criscitiello (36106_CR15) 2006; 103 S Muyldermans (36106_CR10) 2021; 9 OC Ubah (36106_CR33) 2021; 12 RL Stanfield (36106_CR16) 2007; 367 H Dooley (36106_CR12) 2006; 103 MG Joyce (36106_CR17) 2021; 37 VD Menachery (36106_CR7) 2016; 113 J Huo (36106_CR36) 2020; 28 HAD King (36106_CR19) 2021; 118 A Berthelmann (36106_CR37) 2014; 12 K Modjarrad (36106_CR4) 2020; 20 J Xu (36106_CR32) 2021; 595 |
| References_xml | – volume: 588 start-page: 682 year: 2020 end-page: 687 ident: CR35 article-title: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies publication-title: Nature doi: 10.1038/s41586-020-2852-1 – volume: 40 start-page: 25 year: 2003 end-page: 33 ident: CR11 article-title: Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display publication-title: Mol. Immunol. doi: 10.1016/S0161-5890(03)00084-1 – volume: 103 start-page: 1846 year: 2006 end-page: 1851 ident: CR12 article-title: First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0508341103 – volume: 7 start-page: 15 year: 2015 end-page: 25 ident: CR9 article-title: Structural insights and biomedical potential of IgNAR scaffolds from sharks publication-title: MAbs doi: 10.4161/19420862.2015.989032 – volume: 12 start-page: 2606 year: 2014 end-page: 2614 ident: CR37 article-title: Versatile C(3)-symmetric scaffolds and their use for covalent stabilization of the foldon trimer publication-title: Org. Biomol. Chem. doi: 10.1039/C3OB42251H – volume: 366 start-page: 8 year: 2011 end-page: 19 ident: CR42 article-title: A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2010.12.016 – volume: 9 start-page: 401 year: 2021 end-page: 421 ident: CR10 article-title: Applications of nanobodies publication-title: Annu Rev. Anim. Biosci. doi: 10.1146/annurev-animal-021419-083831 – volume: 103 start-page: 5036 year: 2006 end-page: 5041 ident: CR15 article-title: An evolutionarily mobile antigen receptor variable region gene: doubly rearranging NAR-TcR genes in sharks publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0507074103 – volume: 118 start-page: e2101918118 year: 2021 ident: CR27 article-title: Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice publication-title: Proc. Natl Acad. Sci. USA. doi: 10.1073/pnas.2101918118 – volume: 105 start-page: 19944 year: 2008 end-page: 19949 ident: CR6 article-title: Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0808116105 – volume: 35 start-page: 936 year: 2005 end-page: 945 ident: CR41 article-title: Shark immunity bites back: Affinity maturation and memory response in the nurse shark, Ginglymostoma cirratum publication-title: Eur. J. Immunol. doi: 10.1002/eji.200425760 – volume: 115 start-page: 103873 year: 2021 ident: CR14 article-title: The immunoglobulins of cartilaginous fishes publication-title: Dev. Comp. Immunol. doi: 10.1016/j.dci.2020.103873 – volume: 184 start-page: 1804 year: 2021 end-page: 1820 e1816 ident: CR38 article-title: Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection publication-title: Cell doi: 10.1016/j.cell.2021.02.026 – volume: 118 start-page: e2106433118 year: 2021 ident: CR19 article-title: Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.2106433118 – volume: 19 year: 2021 ident: CR26 article-title: Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein publication-title: J. Nanobiotechnol. doi: 10.1186/s12951-021-00768-w – volume: 48 start-page: 2027 year: 2011 end-page: 2037 ident: CR40 article-title: Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2011.06.437 – volume: 374 start-page: 168 year: 1995 end-page: 173 ident: CR13 article-title: A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks publication-title: Nature doi: 10.1038/374168a0 – volume: 12 year: 2021 ident: CR33 article-title: Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography publication-title: Nat. Commun. doi: 10.1038/s41467-021-27611-y – volume: 181 start-page: 1004 year: 2020 end-page: 1015 e1015 ident: CR22 article-title: Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies publication-title: Cell doi: 10.1016/j.cell.2020.04.031 – volume: 22 start-page: 1503 year: 2021 end-page: 1514 ident: CR34 article-title: Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations publication-title: Nat. Immunol. doi: 10.1038/s41590-021-01068-z – volume: 13 start-page: 1958663 year: 2021 ident: CR28 article-title: Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies publication-title: MAbs doi: 10.1080/19420862.2021.1958663 – volume: 367 start-page: 1260 year: 2020 end-page: 1263 ident: CR21 article-title: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation publication-title: Science doi: 10.1126/science.abb2507 – volume: 14 start-page: eabi5735 year: 2022 ident: CR18 article-title: A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates publication-title: Sci. Transl. Med doi: 10.1126/scitranslmed.abi5735 – volume: 297 start-page: 101202 year: 2021 ident: CR24 article-title: Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction publication-title: J. Biol. Chem. doi: 10.1016/j.jbc.2021.101202 – volume: 6 year: 2021 ident: CR20 article-title: A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge publication-title: NPJ Vaccines doi: 10.1038/s41541-021-00392-7 – volume: 17 start-page: e1009328 year: 2021 ident: CR31 article-title: A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1009328 – volume: 28 start-page: 445 year: 2020 end-page: 454 e446 ident: CR36 article-title: Neutralization of SARS-CoV-2 by destruction of the prefusion spike publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.06.010 – volume: 14 start-page: 523 year: 2016 end-page: 534 ident: CR3 article-title: SARS and MERS: Recent insights into emerging coronaviruses publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro.2016.81 – volume: 20 start-page: 760 year: 2020 end-page: 761 ident: CR4 article-title: Two Middle East respiratory syndrome vaccines: First step for other coronavirus vaccines? publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(20)30317-0 – volume: 113 start-page: 3048 year: 2016 end-page: 3053 ident: CR7 article-title: SARS-like WIV1-CoV poised for human emergence publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.1517719113 – volume: 371 start-page: eabe6230 year: 2021 ident: CR25 article-title: Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape publication-title: Science doi: 10.1126/science.abe6230 – volume: 595 start-page: 278 year: 2021 end-page: 282 ident: CR32 article-title: Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants publication-title: Nature doi: 10.1038/s41586-021-03676-z – volume: 117 start-page: 23652 year: 2020 end-page: 23662 ident: CR1 article-title: A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.2008281117 – volume: 45 start-page: 148 year: 2020 ident: CR8 article-title: COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development publication-title: J. Biosci. doi: 10.1007/s12038-020-00114-6 – volume: 370 start-page: 1479 year: 2020 end-page: 1484 ident: CR23 article-title: Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2 publication-title: Science doi: 10.1126/science.abe4747 – volume: 367 start-page: 358 year: 2007 end-page: 372 ident: CR16 article-title: Maturation of shark single-domain (IgNAR) antibodies: evidence for induced-fit binding publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2006.12.045 – volume: 11 year: 2021 ident: CR29 article-title: Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody publication-title: Sci. Rep. doi: 10.1038/s41598-021-82833-w – volume: 64 start-page: 215 year: 2019 end-page: 223 ident: CR2 article-title: COVID-19 outbreak: An overview publication-title: Chemotherapy doi: 10.1159/000507423 – volume: 22 start-page: e52325 year: 2021 ident: CR30 article-title: NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies publication-title: EMBO Rep. doi: 10.15252/embr.202052325 – volume: 82 start-page: 2274 year: 2008 end-page: 2285 ident: CR5 article-title: Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium publication-title: J. Virol. doi: 10.1128/JVI.02041-07 – volume: 37 start-page: 110143 year: 2021 ident: CR17 article-title: SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.110143 – volume: 54 start-page: 2143 year: 2021 end-page: 2158 e2115 ident: CR39 article-title: Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy publication-title: Immunity doi: 10.1016/j.immuni.2021.08.015 – volume: 588 start-page: 682 year: 2020 ident: 36106_CR35 publication-title: Nature doi: 10.1038/s41586-020-2852-1 – volume: 17 start-page: e1009328 year: 2021 ident: 36106_CR31 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1009328 – volume: 366 start-page: 8 year: 2011 ident: 36106_CR42 publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2010.12.016 – volume: 105 start-page: 19944 year: 2008 ident: 36106_CR6 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0808116105 – volume: 14 start-page: eabi5735 year: 2022 ident: 36106_CR18 publication-title: Sci. Transl. Med doi: 10.1126/scitranslmed.abi5735 – volume: 595 start-page: 278 year: 2021 ident: 36106_CR32 publication-title: Nature doi: 10.1038/s41586-021-03676-z – volume: 20 start-page: 760 year: 2020 ident: 36106_CR4 publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(20)30317-0 – volume: 370 start-page: 1479 year: 2020 ident: 36106_CR23 publication-title: Science doi: 10.1126/science.abe4747 – volume: 54 start-page: 2143 year: 2021 ident: 36106_CR39 publication-title: Immunity doi: 10.1016/j.immuni.2021.08.015 – volume: 103 start-page: 1846 year: 2006 ident: 36106_CR12 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0508341103 – volume: 297 start-page: 101202 year: 2021 ident: 36106_CR24 publication-title: J. Biol. Chem. doi: 10.1016/j.jbc.2021.101202 – volume: 7 start-page: 15 year: 2015 ident: 36106_CR9 publication-title: MAbs doi: 10.4161/19420862.2015.989032 – volume: 367 start-page: 358 year: 2007 ident: 36106_CR16 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2006.12.045 – volume: 181 start-page: 1004 year: 2020 ident: 36106_CR22 publication-title: Cell doi: 10.1016/j.cell.2020.04.031 – volume: 13 start-page: 1958663 year: 2021 ident: 36106_CR28 publication-title: MAbs doi: 10.1080/19420862.2021.1958663 – volume: 184 start-page: 1804 year: 2021 ident: 36106_CR38 publication-title: Cell doi: 10.1016/j.cell.2021.02.026 – volume: 64 start-page: 215 year: 2019 ident: 36106_CR2 publication-title: Chemotherapy doi: 10.1159/000507423 – volume: 11 year: 2021 ident: 36106_CR29 publication-title: Sci. Rep. doi: 10.1038/s41598-021-82833-w – volume: 118 start-page: e2101918118 year: 2021 ident: 36106_CR27 publication-title: Proc. Natl Acad. Sci. USA. doi: 10.1073/pnas.2101918118 – volume: 14 start-page: 523 year: 2016 ident: 36106_CR3 publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro.2016.81 – volume: 22 start-page: 1503 year: 2021 ident: 36106_CR34 publication-title: Nat. Immunol. doi: 10.1038/s41590-021-01068-z – volume: 40 start-page: 25 year: 2003 ident: 36106_CR11 publication-title: Mol. Immunol. doi: 10.1016/S0161-5890(03)00084-1 – volume: 22 start-page: e52325 year: 2021 ident: 36106_CR30 publication-title: EMBO Rep. doi: 10.15252/embr.202052325 – volume: 374 start-page: 168 year: 1995 ident: 36106_CR13 publication-title: Nature doi: 10.1038/374168a0 – volume: 19 year: 2021 ident: 36106_CR26 publication-title: J. Nanobiotechnol. doi: 10.1186/s12951-021-00768-w – volume: 12 year: 2021 ident: 36106_CR33 publication-title: Nat. Commun. doi: 10.1038/s41467-021-27611-y – volume: 6 year: 2021 ident: 36106_CR20 publication-title: NPJ Vaccines doi: 10.1038/s41541-021-00392-7 – volume: 35 start-page: 936 year: 2005 ident: 36106_CR41 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200425760 – volume: 9 start-page: 401 year: 2021 ident: 36106_CR10 publication-title: Annu Rev. Anim. Biosci. doi: 10.1146/annurev-animal-021419-083831 – volume: 45 start-page: 148 year: 2020 ident: 36106_CR8 publication-title: J. Biosci. doi: 10.1007/s12038-020-00114-6 – volume: 115 start-page: 103873 year: 2021 ident: 36106_CR14 publication-title: Dev. Comp. Immunol. doi: 10.1016/j.dci.2020.103873 – volume: 103 start-page: 5036 year: 2006 ident: 36106_CR15 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0507074103 – volume: 113 start-page: 3048 year: 2016 ident: 36106_CR7 publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.1517719113 – volume: 48 start-page: 2027 year: 2011 ident: 36106_CR40 publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2011.06.437 – volume: 367 start-page: 1260 year: 2020 ident: 36106_CR21 publication-title: Science doi: 10.1126/science.abb2507 – volume: 117 start-page: 23652 year: 2020 ident: 36106_CR1 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.2008281117 – volume: 371 start-page: eabe6230 year: 2021 ident: 36106_CR25 publication-title: Science doi: 10.1126/science.abe6230 – volume: 12 start-page: 2606 year: 2014 ident: 36106_CR37 publication-title: Org. Biomol. Chem. doi: 10.1039/C3OB42251H – volume: 37 start-page: 110143 year: 2021 ident: 36106_CR17 publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.110143 – volume: 82 start-page: 2274 year: 2008 ident: 36106_CR5 publication-title: J. Virol. doi: 10.1128/JVI.02041-07 – volume: 118 start-page: e2106433118 year: 2021 ident: 36106_CR19 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.2106433118 – volume: 28 start-page: 445 year: 2020 ident: 36106_CR36 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.06.010 |
| SSID | ssj0000391844 |
| Score | 2.5159192 |
| Snippet | Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse... SARS-CoV-2 variants of concern continue to emerge, reducing vaccine efficacy and limiting therapeutic options. Here, Chen and colleagues describe the... |
| SourceID | doaj pubmedcentral osti proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 580 |
| SubjectTerms | 101/47 13/1 60 APPLIED LIFE SCIENCES 631/154/51/1568 631/250/255/2514 631/535/1266 631/61/24 64/110 82/80 9/10 Affinity Animals Antibodies Antibodies, Neutralizing Antibodies, Viral antibody therapy Antigens applied immunology Chimeras COVID-19 COVID-19 - prevention & control Epitopes Ferritin Ferritins - genetics Humanities and Social Sciences Immunization Immunoglobulin Fc Fragments Mice Mice, Transgenic multidisciplinary Nanobodies Nanoparticles Neutralization Pandemics Receptors SARS-CoV-2 - genetics Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 Severe acute respiratory syndrome-related coronavirus Sharks Single-Domain Antibodies Spike Glycoprotein, Coronavirus - genetics Spike protein Transgenic mice Vaccine efficacy Vaccines Viral diseases viral infection x-ray crystallography |
| SummonAdditionalLinks | – databaseName: Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDehBRmJG1hNbCexj6WiqpDgQCnqzRo_IipQUu1mUeHXM-Nkly7PC6dIG68Sz8PzTTz-hrFnAZKUYCthwVuBEUoKG4MUIFXThKCC1HTe-c3b5vhUvz6rz660-qKasIkeeBLcvrGmS0Yq7zvMXEwCogwDGUvQVQcyH_PFmHclmcprsLKYuuj5lEypzP5S5zUBQ5RQCBkacbkViTJhP14GdKzfgc1fayZ_2jjN8ejoFrs5A0l-ME3gNruW-jvs-tRa8utd5oiJ-RPvoR_8QJWCnL648osBMfLITw7enYjD4YOQvE-r_LHjGz6F0ykHaibBoY_cLwaIfAkLVMDw5XyxWnJEmPOIe-z06NX7w2MxN1MQoW7aUUAIbRl9rILtdNRNmUxroIOI8d2WKZgudjG2spalDihtrxoTOw2txiUxKa3us51-6NNDxsvaSO8bq5SNiAfAStkR1Klj0wJmSAWr1oJ1YWYap4YXn13e8VbGTcpwqAyXleEuC_Z885-LiWfjr6Nfkr42I4kjO_-AluNmy3H_spyC7ZK2HUIN4ssNVFgURkcAE7O6gu2tjcDNbr10EnORymrZ4hyfbm6jQ9IuC_RpWOUxCpNMpdqCPZhsZvOeiroCIUAtWLtlTVsT2b7Tn3_MpN_WWISutmAv1nb347X-LKhH_0NQu-yGJL-hWnW1x3bGxSo9Rig2-ifZ674DOWsvLw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k1oQUbiBlaztpPYJ1QqlgoJDpSi3izHdqACxUuSRYVfz4yTTbU8eoq08SpxZsbzzXj8DSHPnA2cW71g2taagYfiTHvHmeWiLJ0Tjks87_zufXl0It-eFqdTwq2fyio3a2JaqH10mCPf5wADIeDmFX-5-s6waxTurk4tNK6SawvwNFjSpZZv5hwLsp8rKaezMrlQ-71MKwM4KiYAOJTsfMsfJdp-uEQwr39Bzr8rJ__YPk1eaXmL3JzgJD0Y5X-bXAntHXJ9bDD58y4xyMf8lba2jXXEekGKeVe6ioCUB3p88OGYHcZPjNM2rFPK4xc8heJZB2wpQW3rad1F62lvOxBD_HHWrXsKOHMacY-cLF9_PDxiU0sF5oqyGph1rsp97RdON9LLMg-qUraxHry8zoNTjW-8r3jBc-lEXdeiVL6RtpKwMAYhxX2y08Y2PCQ0LxSv61ILoT2gAqs5bxDwFL6sLMRJGVlsPqxxE984tr34ZtK-t1BmFIYBYZgkDHOekefzf1Yj28alo1-hvOaRyJSdfojdZzMZnlFaNUFxmEsDka8KFinnLPe5lYvGcpWRXZS2AcCBrLkOy4vcYBBmQmyXkb2NEpjJuHtzoYoZeTrfBrPEvRbbhrhOYwSEmkJUGXkw6sz8ngJ7AwFMzUi1pU1bE9m-0559SdTfWmkAsDojLzZ6d_Fa__9Qjy6fxS65wdEisBZd7JGdoVuHxwC1hvpJsqffWVQmjQ priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA-lRfBF_HZtlQi-aXAvye4mj2exlAN98Kz0LWSTrJbKpuztifrXO5P9kNMq-HRwO8slmZmb3yST3xDy3NnAudULpm2tGUQozrR3nFkuytI54bjE-85v35WnZ3J1XpzvET7dhUlF-4nSMv1NT9VhrzYyuTREGCYg4pcMcOMBUrWDbR8sl6v1at5ZQc5zJeV4QyYX6pqXd6JQIuuHjwhOdR3Q_LNe8rdD0xSLTm6TWyOIpMth2HfIXmjvkhtDW8nv94hBFuZL2to21hGrBCnuttKrCPi4p-vl-zU7jh8Zp23Ypo2OH_ArFG84YCMJaltP6y5aTze2g8WPXy-67YYCuhwl7pOzkzcfjk_Z2EiBuaKsemadq3Jf-4XTjfSyzIOqlG2sh9iu8-BU4xvvK17wXDpR17UolW-kxeVVQUjxgOy3sQ2PCM0Lxeu61EJoD1jAas4bhDmFLysL2VFGFtPCGjeyjGOziy8mnXYLZQZlGFCGScow3zLyYn7nauDY-Kf0a9TXLIn82OmL2H0yo70YpVUTFIe5NJDvqmCRaM5yn1u5aCxXGTlEbRuAGciV67CoyPUGwSVkdBk5mozAjC69MRzykIWWvII5PpsfgzPiCYttQ9wmGQEJphBVRh4ONjOPU2BHIACnGal2rGlnIrtP2ovPifBbKw2wVWfk5WR3v4b194V6_H_ih-QmRw_BinRxRPb7bhueAODq66ejh_0ELxEmMA priority: 102 providerName: Springer Nature |
| Title | Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity |
| URI | https://link.springer.com/article/10.1038/s41467-023-36106-x https://www.ncbi.nlm.nih.gov/pubmed/36737435 https://www.proquest.com/docview/2772194272 https://www.proquest.com/docview/2773114337 https://www.osti.gov/servlets/purl/2423606 https://pubmed.ncbi.nlm.nih.gov/PMC9896449 https://doaj.org/article/898fe823bbf4468ea5527a2d0a41fa28 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfGJiReEN-EjcpIvIEhsd3YfkCoq1amSpvQSlHfLMd2xsSUjLRFG389ZyctKhSeeIklfyi27873O3_cIfTSGk-pURlRplAENBQlyllKDGV5bi2zlIf3zien-fGUj2f92Q5ahTvqJnC-1bQL8aSmzeWb628370Hg37VPxuXbOY_iDtqHMEADOQFMuQeaSYSIBicd3I8rM1Ng0PDu7cz2phv6Kbrxh6QGcdsGQf-8SfnbcWrUUqN76G4HL_Gg5Yf7aMdXD9DtNuDkzUOkg3_mr7gyVV3U4f4gDvuw-KoG5LzAk8HZhAzrz4Tiyi_jFsgP-AsObx9CiAlsKoeLpjYOz00DZKm_XzTLOQbc2dV4hKajo0_DY9KFWCC2n4sFMdaK1BUus6rkjuepl0Ka0jjQ-ir1VpaudE7QPk25ZUVRsFy6khvBYaH0jLPHaLeqK_8U4bQvaVHkijHlACUYRWkZAFDf5cKA3ZSgbDWx2nb-x0MYjEsdz8GZ1C0xNBBDR2Lo6wS9Wre5ar1v_LP2YaDXumbwnB0z6uZcd4KopZKllxTGUoIlLL0JLugMdanhWWmoTNB-oLYGABK86Npw3cgudICdYOsl6GDFBHrFq5qChZIpTgWM8cW6GMQ0nL2YytfLWIeB6cmYSNCTlmfW_WQhVhDA1gSJDW7aGMhmSXXxJboCV1IBoFUJer3iu1_d-vtEPfsfE7WP7tAgN-EGOztAu4tm6Z8DQFsUPXRLzAR85ehDD-0NBuPJGNLDo9OPZ5A7zIe9uPXRi9L5E9K9PdE |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKEYILYie0gJHgBFYztiexDwiVwjCly4G2qDfXsR2oQPEwC7T8KH4j72WZalh662mkxMnEftv37LcQ8tTZwLnVPaZtoRlYKM60d5xZLrLMOeG4xHznnd1seCDfH_YPl8ivLhcGwyo7nVgrah8d7pGvcYCB4HDznL8afWPYNQpPV7sWGg1bbIXTH-CyTV5uvgH6PuN88HZ_Y8jargLM9bN8yqxzeeoL33O6lF5maVC5sqX1YOh0Gpwqfel9zvs8lU4URSEy5Utpcwm6IQgp4L2XyGUpwJJjZvrg3XxPB6utKynb3JxUqLWJrDURGEYmAKhk7GTB_tVtAuAngjj_C-L-Han5x3FtbQUHN8j1Fr7S9YbfbpKlUN0iV5qGlqe3icH6z19oZatYRIxPpLjPS0cRkPmU7q1_2GMb8SPjtAqzeovlJ_wLxdwKbGFBbeVpMY7W04kdA9nj9-PxbEIB17Yj7pCDC1nsu2S5ilW4T2jaV7woMg3r7gGFWM15iQCr77Pcgl-WkF63sMa19c2xzcZXU5-zC2UaYhgghqmJYU4S8nz-zKip7nHu6NdIr_lIrMxdX4jjT6YVdKO0KoPiMJcSPG0VLJa4s9ynVvZKy1VCVpDaBgAOVul1GM7kpgZhLfiSCVntmMC0ymRizlg_IU_mt0EN4NmOrUKc1WMEuLZC5Am51_DM_DsF9iICWJyQfIGbFiayeKc6_lyXGtdKA2DWCXnR8d3ZZ_1_oR6cP4vH5Opwf2fbbG_ubq2QaxylA-PgxSpZno5n4SHAvGnxqJYtSo4uWph_A8rJZSk |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEG9CCxgJTmBt1s4m9gGhvlYthVXVUtSbcWwHKlBS9gEtP41fx0yS3Wp59NZTpMRJbM_rG3s8A_DM2SCE1T2uba45WijBtXeCWyHT1DnpRELnnd8N0-3D5M1R_2gJfs3OwlBY5Uwn1oraV47WyLsCYSA63CIT3aINi9jbHLw--capghTttM7KaTQsshvOfqD7Nn61s4m0fi7EYOv9xjZvKwxw10-zCbfOZbHPfc_pIvFJGgeVKVtYj0ZPx8GpwhfeZ6Iv4sTJPM9lqnyR2CxBPRFkIvG7V2A5I6-oA8vrW8O9_fkKD-VeV0nSntSJpeqOk1ovoZnkEmFLyk8XrGFdNAAvFQr3vwDv33Gbf2ze1jZxcBNutGCWrTXcdwuWQnkbrjblLc_ugKFs0F9YacsqryhakdGqLzupEKdP2MHa_gHfqD5wwcowrRdcfuJfGJ20oIIWzJae5aPKeja2I2SC6vvxaDpmiHLbFnfh8FKm-x50yqoMD4DFfSXyPNVSao-YxGohCoJbfZ9mFr20CHqziTWuzXZORTe-mnrXXSrTEMMgMUxNDHMawYv5OydNro8LW68TveYtKU93faMafTKt2BulVRGUwLEU6HerYCnhnRU-tkmvsEJFsELUNgh3KGevo-AmNzEEctGzjGB1xgSmVS1jcy4IETydP0alQDs9tgzVtG4j0dGVMovgfsMz835KqkyEIDmCbIGbFgay-KQ8_lwnHtdKI3zWEbyc8d15t_4_UQ8vHsUTuIaCbN7uDHdX4Log4aCgeLkKncloGh4h5pvkj1vhYvDxsuX5N2ZPars |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shark+nanobodies+with+potent+SARS-CoV-2+neutralizing+activity+and+broad+sarbecovirus+reactivity&rft.jtitle=Nature+communications&rft.au=Wei-Hung+Chen&rft.au=Agnes+Hajduczki&rft.au=Elizabeth+J.+Martinez&rft.au=Hongjun+Bai&rft.date=2023-02-03&rft.pub=Nature+Portfolio&rft.eissn=2041-1723&rft.volume=14&rft.issue=1&rft.spage=1&rft.epage=18&rft_id=info:doi/10.1038%2Fs41467-023-36106-x&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_898fe823bbf4468ea5527a2d0a41fa28 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |